Large-scale head-to-head comparison of on- and off-target profiles of [18F]Tauvid and [18F]MK6240 tau-PET in aging and Alzheimer’s disease
Abstract
Background Tau-PET imaging enables in vivo quantification of neurofibrillary tangles, but tracers such as [ 18 F]Tauvid and [ 18 F]MK6240 present distinct affinities and off-target binding properties. Using the multicenter HEAD research cohort, a large-scale study designed to characterize the aging and Alzheimer’s disease (AD) spectrum, this study directly compares tracer performance to support harmonization across cohorts and clinical trials. Methods 681 participants underwent MRI, amyloid-β (Aβ)-PET, and tau-PET scans with both [ 18 F]Tauvid and [ 18 F]MK6240. We analyzed regions reflecting AD-related tau deposition (on-target) and known age-related or off-target binding. Analyses included paired t-tests, linear regressions, effect sizes and correlation matrices between the two tracers, across on-target and off-target regions. We further assessed tracer signal separation quantifying the noise to dynamic range ratio (NRR), where lower values indicate better assessment of tau. Results Tracers showed strong correlations in on-target regions (R = 0.81–0.95 in the whole cohort; R = 0.83–0.95 in Aβ+; R = 0.59–0.71 in Aβ-), supporting robust tau pathology detection. While off-target regions also correlated (R = 0.58–0.74 in the whole cohort; R = 0.55–0.80 in Aβ+; R = 0.57–0.73 in Aβ-), retention magnitudes differed: [ 18 F]Tauvid presented higher retention in the white matter, basal ganglia and choroid plexus, while [ 18 F]MK6240 had higher retention in the meninges and extracortical region near the entorhinal cortex. Voxelwise paired t-tests and NRR analyses, conducted at both ROI and voxelwise levels, demonstrated that [ 18 F]MK6240 consistently yielded lower NRR values across the cortex, indicating better signal separation, and potentially greater sensitivity for detecting early tau accumulation. Conclusion [ 18 F]Tauvid and [ 18 F]MK6240 capture largely overlapping patterns of tau pathology, but differ notably in the magnitude of off-target binding. These findings highlight the importance of understanding tracer similarities and differences to guide tracer selection and to improve harmonization across studies. Independent and tracer-specific optimizations of pipelines are essential before harmonization across tracers can be achieved, thereby facilitating accurate cross-study comparisons and improving clinical translation. Trial Registration: NCT05361382
Related
- Integrating Multisource Target Evidence with Machine-Learning Potency Prediction for Alzheimer's Disease Drug Discovery
- ARSA: an autonomous research scientist for target nomination in Alzheimer's disease and related dementias
- Plasma Proteomic Profiles of Alzheimer's Disease and Neurodegeneration in African Cohorts
- Electroencephalography-based Alzheimer's disease detection using multi-scale information retention transform: a subject-level comparison of machine learning classifiers
- Comparison of Giemsa and Hemacolor Staining Reveals Systematic Differences in Avian Leukocyte Profiles
BibTeX
@misc{tissot2026largescale,
title = {{Large-scale head-to-head comparison of on- and off-target profiles of [18F]Tauvid and [18F]MK6240 tau-PET in aging and Alzheimer’s disease}},
author = {Cécile Tissot and Hsin-Yeh Tsai and Ji Yeon Lee and Nesrine Rahmouni and Firoza Z. Lussier and Corrina S. Fonseca and Joseph Therriault and Jenna Stevenson and Arthur C. Macedo and Mahnaz Shekari and Guilherme Povala and Pâmela C. Lukasewicz Ferreira and Bruna Bellaver and Guilherme Bauer-Negrini and Renaud LaJoie and Brian A. Gordon and Belen Pascual and Val Lowe and David Soleimani-Meigooni and Hwamee Oh and Juan Fortea and William Klunk and Pedro Rosa-Neto and William J. Jagust and Tharick Pascoal and Suzanne L. Baker and HEAD study},
howpublished = {Research Square},
year = {2026},
month = nov,
doi = {10.21203/rs.3.rs-9987995/v1},
url = {https://doi.org/10.21203/rs.3.rs-9987995/v1},
note = {CC BY 4.0},
}
RIS
TY - UNPB
TI - Large-scale head-to-head comparison of on- and off-target profiles of [18F]Tauvid and [18F]MK6240 tau-PET in aging and Alzheimer’s disease
AU - Cécile Tissot
AU - Hsin-Yeh Tsai
AU - Ji Yeon Lee
AU - Nesrine Rahmouni
AU - Firoza Z. Lussier
AU - Corrina S. Fonseca
AU - Joseph Therriault
AU - Jenna Stevenson
AU - Arthur C. Macedo
AU - Mahnaz Shekari
AU - Guilherme Povala
AU - Pâmela C. Lukasewicz Ferreira
AU - Bruna Bellaver
AU - Guilherme Bauer-Negrini
AU - Renaud LaJoie
AU - Brian A. Gordon
AU - Belen Pascual
AU - Val Lowe
AU - David Soleimani-Meigooni
AU - Hwamee Oh
AU - Juan Fortea
AU - William Klunk
AU - Pedro Rosa-Neto
AU - William J. Jagust
AU - Tharick Pascoal
AU - Suzanne L. Baker
AU - HEAD study
PY - 2026
DA - 2026/11/01
PB - Research Square
DO - 10.21203/rs.3.rs-9987995/v1
UR - https://doi.org/10.21203/rs.3.rs-9987995/v1
AB - Background Tau-PET imaging enables in vivo quantification of neurofibrillary tangles, but tracers such as [ 18 F]Tauvid and [ 18 F]MK6240 present distinct affinities and off-target binding properties. Using the multicenter HEAD research cohort, a large-scale study designed to characterize the aging and Alzheimer’s disease (AD) spectrum, this study directly compares tracer performance to support harmonization across cohorts and clinical trials. Methods 681 participants underwent MRI, amyloid-β (Aβ)-PET, and tau-PET scans with both [ 18 F]Tauvid and [ 18 F]MK6240. We analyzed regions reflecting AD-related tau deposition (on-target) and known age-related or off-target binding. Analyses included paired t-tests, linear regressions, effect sizes and correlation matrices between the two tracers, across on-target and off-target regions. We further assessed tracer signal separation quantifying the noise to dynamic range ratio (NRR), where lower values indicate better assessment of tau. Results Tracers showed strong correlations in on-target regions (R = 0.81–0.95 in the whole cohort; R = 0.83–0.95 in Aβ+; R = 0.59–0.71 in Aβ-), supporting robust tau pathology detection. While off-target regions also correlated (R = 0.58–0.74 in the whole cohort; R = 0.55–0.80 in Aβ+; R = 0.57–0.73 in Aβ-), retention magnitudes differed: [ 18 F]Tauvid presented higher retention in the white matter, basal ganglia and choroid plexus, while [ 18 F]MK6240 had higher retention in the meninges and extracortical region near the entorhinal cortex. Voxelwise paired t-tests and NRR analyses, conducted at both ROI and voxelwise levels, demonstrated that [ 18 F]MK6240 consistently yielded lower NRR values across the cortex, indicating better signal separation, and potentially greater sensitivity for detecting early tau accumulation. Conclusion [ 18 F]Tauvid and [ 18 F]MK6240 capture largely overlapping patterns of tau pathology, but differ notably in the magnitude of off-target binding. These findings highlight the importance of understanding tracer similarities and differences to guide tracer selection and to improve harmonization across studies. Independent and tracer-specific optimizations of pipelines are essential before harmonization across tracers can be achieved, thereby facilitating accurate cross-study comparisons and improving clinical translation. Trial Registration: NCT05361382
SN - 2693-5015
ER -